On Wednesday, in the course of current trade, Shares of Ascena Retail Group Inc. (NASDAQ:ASNA), dropped -1.31%, and is now trading at $14.74.
Ascena Retail Group, declared the release of its Fiscal 2015 third quarter financial results will take place on Tuesday, June 2, 2015. Results will be released over Business Wire at about 4:00 PM Eastern Time. The Company will also host a conference call at 4:30 PM Eastern Time to review its results, which will comprise comments by David Jaffe, President & CEO, and Robb Giammatteo, Senior Vice President & CFO, followed by a question and answer session.
Ascena Retail Group, Inc., through its auxiliaries, operates as a specialty retailer of apparel for women, and tween girls and boys. It operates through five segments: Justice, Lane Bryant, maurices, dressbarn, and Catherines segments.
During an Afternoon trade, Shares of Ally Financial Inc. (NYSE:ALLY), gained 1.17%, and is now trading at $22.51.
Ally Bank, the direct banking partner of Ally Financial, has further expanded its Ally Mobile Banking app to comprise Ally AssistSM, a virtual assistant that responds to customer inquiries in a way that delivers a more intuitive and personalized banking experience. Presently accessible in the Ally Mobile Banking app for iPhone®, Ally Assist also has the ability to predict customer needs by analyzing accounts and transactions to present context-aware topics and messages to customers.
Specifically, users can interact with Ally Assist via speech or text to perform a wide range of tasks, such as:
- Initiate transfers, bill payments, Popmoney® transactions and deposits
- Request detailed information on accounts and transactions
- Obtain information on interest earned and saving/spending patterns.
Ally Financial Inc. provides financial products and services primarily to automotive dealers and their customers in the United States. It offers dealer financial services, counting a range of financial services and insurance products to automotive dealers and retail customers.
Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA), during its Wednesday’s current trading session fell -1.10%, and is now trading at $84.90.
With tremendous support from customers across the country, Walgreens has exceeded its aim of raising $5 million through red nose and vendor partner product sales, in addition to in-store donations in support of the nationwide fundraising campaign, Red Nose Day. With a limited amount of red noses remaining for purchase, Walgreens is offering additional ways for customers to show support as the nation’s largest drugstore continues to exceed its Red Nose Day fundraising aim.
The laughter building up to Red Nose Day on May 21 continues, and it’s still easy to get involved in this fun-filled campaign to assist lift children out of poverty. Through May 30, Walgreens customers can make donations to support Red Nose Day in-store or by purchasing select products at Walgreens from vendor partners such as Mars, Kraft and Coca-Cola. They also can tune in and donate during NBC’s televised fundraising event May 21 (8-11 p.m. Eastern time). Customers are even encouraged to get creative, flexing their DIY skills for a personal take on the red nose and take a #RedNose selfie.
Walgreens Boots Alliance, Inc., together with its auxiliaries, operates a network of drugstores in the United States. It provides consumer goods and services, pharmacy, and health and wellness services through drugstores, in addition to through mail, and by telephone and online.
Finally, Laboratory Corp. of America Holdings (NYSE:LH), gained 1.04% Wednesday.
ORIG3N, Inc., a pioneer in regenerative medicine and provider of induced pluripotent stem cell (iPSC) storage, called LifeCapsule (www.capsule.life), declared a planned partnership with Laboratory Corporation of America® Holdings (LabCorp®) (LH). LabCorp has invested in ORIG3N, and will provide storage for LifeCapsule at its biorepository facilities in addition to perform genetic testing on the stored cells. LabCorp’s expertise will assist to accelerate the development of LifeCapsule’s specimen repository.
LifeCapsule’s repository is utilized to generate induced pluripotent stem cells (iPSCs). These cells can be differentiated to every other cell type in the human body, which aids in more accurate disease modeling and drug efficacy testing. The repository will enable access to a large, genetically diverse population of iPSCs for biotechnology and pharmaceutical companies, supporting development of treatments for a variety of diseases. The planned partnership between ORIG3N and LabCorp will enhance the utility of LifeCapsule and establish a well characterized library of specimens.
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. The company offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, STD tests, HCV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by the medical profession in core testing, patient diagnosis, and in the monitoring and treatment of diseases.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
